Xiang Yu

The STAT1/HMGB1/NF-κB pathway in chronic inflammation and kidney injury after cisplatin exposure

Ying Fu, Xiang Yu, Ying Wang et al. · Theranostics · 2023 · 94 citations · Full text

Medicine, Oncology, Pharmacology +17

Targeted VEGFA therapy in regulating early acute kidney injury and late fibrosis

Mengjie Huang, Yuwei Ji, Jianwen Chen et al. · Acta Pharmacologica Sinica · 2023 · 43 citations · Full text

Medicine, Molecular Medicine, Nephrology +16

Persistent Activation of Autophagy After Cisplatin Nephrotoxicity Promotes Renal Fibrosis and Chronic Kidney Disease

Ying Fu, Xiang Yu, Wenwen Wu et al. · Frontiers in Pharmacology · 2022 · 30 citations · Full text

Medicine, Nephrology, Pharmacology +17

Identifying Patients at Risk of Acute Kidney Injury among Patients Receiving Immune Checkpoint Inhibitors: A Machine Learning Approach

Xiang Yu, Rilige Wu, Yuwei Ji et al. · Diagnostics · 2022 · 19 citations · Full text

Medicine, Nephrology, Oncology +17

Enhanced STAT3/PIK3R1/mTOR signaling triggers tubular cell inflammation and apoptosis in septic-induced acute kidney injury: implications for therapeutic intervention

Ying Fu, Xiang Yu, Jie Zha et al. · Clinical Science · 2024 · 11 citations · Full text

Life Sciences, Pathobiology, Pharmacology +17